Home
News
Press Releases and Articles
Calendar of Events
How to Help
Gates Foundation Grant to GAELF
The Global Alliance
Global Alliance History
Goals
Global Alliance Structure
Executive Group
Partnerships
GAELF Logo
LF Webring
About LF
What is LF?
How is LF Contracted?
How is LF Diagnosed?
Prevent/Eliminate LF
Manage LF
LF and Children
Additional Treatment Benefits
LF Slideshow
In Depth Disease Info
Where is LF?
Countries and Map List
Moving Forward
Starting Out
Success Stories
Progress and Plans
Elimination Strategy
Operational Research
Progress to Date
Economics of LF
Return on Investment
The Way Ahead
Highlighted Programmes
   Burkina Faso
   Sri Lanka

For the Media
Press Release Archive
Press Kits
Photos
Articles
Video Clips
Media Contacts
FAQs
Publications
LF News
Annual Reports
General Publications
Training Material
Videos
Journal Articles & Other Pubs
EG Updates
Gates Foundation

Diagnosis

Until recently, diagnosis of filarial infection depended on the direct demonstration of the parasite (almost always microfilariae) in blood using relatively cumbersome techniques and having to take into account the periodicity (nocturnal or diurnal) of microfilariae. Alternative methods based on detection of antibodies by immunodiagnostic tests did not prove satisfactory since they both failed to distinguish between active and past infections and had problems with specificity owing to their cross-reactivity with common gastrointestinal parasites and other organisms.

Antigen detection: Circulating filarial antigen (CFA) detection should now be regarded as the 'gold standard' for diagnosing Wuchereria bancrofti infections. The specificity of these assays is excellent, and the sensitivity is greater than that achievable by the earlier parasite-detection assays. Essentially all individuals with microfilaraemia also have detectable circulating antigen, as well as do a proportion of those amicrofilaraemic individuals with clinical manifestations of filariasis (e.g., lymphoedema or elephantiasis) but no circulating microfilariae. In addition, some individuals who appear normal also have detectable circulating antigen that disappears after effective treatment with DEC for these cryptic infections. Two commercial configurations of this assay are available, one based on ELISA methodology that yields semi-quantitative results, and the other based on a simple card (immunochromatographic) test, yielding only qualitative (positive/negative) answers. Thus, this new diagnostic approach is equally applicable to clinical or field evaluation of bancroftian filariasis infections. Unfortunately, no such test is currently available for brugian filariasis.

 

© Global Alliance to Eliminate Lymphatic Filariasis